Elsevier Announces New 2012 Frontlist eBooks Collection on SciVerse ScienceDirect Available for Advance Purchase
Poster: SySAdmin
Posted on November 2, 2011 at 9:35:01 AM
Elsevier Announces New 2012 Frontlist eBooks Collection on SciVerse ScienceDirect Available for Advance Purchase
AMSTERDAM, November 2, 2011/PRNewswire-FirstCall/ --
Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, announced today that its 2012
eBook Frontlist collections are available for advance purchase on SciVerse
ScienceDirect, Elsevier's online platform for scientific content. This
release marks a significant increase in the breadth and depth of the eBook
collection on SciVerse ScienceDirect. The 2012 collection covers 23 distinct
subject areas, with individual titles scheduled to publish between January 1
and December 31, 2012.
This year sees an increase in the number of Science and Technology (S&T)
titles, with more than 50% growth strategically delivered in each of the
following top selling collections: Biochemistry, Genetics and Molecular
Biology, Biomedical Science and Medicine, Chemistry and Pharmacology,
Toxicology and Pharmaceutical Science. The chemistry collection alone has
doubled in size while the Health Sciences (HS) Clinical Medicine collection
has increased by 14%. These are all high quality titles, selected for
relevance and published under imprints including Academic Press, Pergamon,
North-Holland, W.B. Saunders, Mosby and Churchill Livingstone.
"Our strategic aim for books on SciVerse ScienceDirect is to grow our
collections in the subjects our customers want and need most, while
retaining our rigorous publication and peer review process to ensure high
quality, " said Suzanne BeDell, Managing Director, Elsevier Science and
Technology Books. "By combining Elsevier's trusted content with the benefits
of accessibility to books, journals, and innovative mobile applications on
the Sciverse ScienceDirect platform, today's academic, government and
corporate institutions are empowered to accelerate research."
Some of the new eBook titles for SciVerse ScienceDirect include:
- Atala/Lanza, Handbook of Stem Cells, 2e
- Crichton, Biological Inorganic Chemistry, 2e
- Wallisch, Matlab for Neuroscientists, 2e
- Waterhouse, Rethinking Autism
- Mettler, Essentials of Nuclear Medicine Imaging, 6e
- Spiro, Clinical Respiratory Medicine, 4e
Librarians, researchers, and those interested in the eBooks 2012
Collections, or any previously published eBooks can visit
http://www.info.sciverse.com/sciencedirect/content/books/lbi
Join our Community:
Facebook http://www.facebook.com/elsevierlibrarians
Twitter http://twitter.com/elsevierscience
About SciVerse ScienceDirect
SciVerse ScienceDirect ( http://www.sciverse.com) contains over a
quarter of the world's full text scientific, technical and medical (STM)
peer-reviewed articles - managed by renowned editors, written by respected
authors and read by researchers from around the globe. Elsevier's extensive
full-text collection covers authoritative titles from the core scientific
literature with more than ten million articles available online. Coverage
includes over 2,500 journal titles published by Elsevier with dynamic
linking to journals from approximately 2,000 STM publishers through
CrossRef. Additionally, SciVerse ScienceDirect contains an expanding library
of online major reference works, handbooks, book series and over 10,000
eBooks in all fields of science seamlessly interlinked with primary research
referenced in journal articles.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Media contact
Harald Boersma
Senior Manager, Corporate Relations, Elsevier
h.boersma@elsevier.com
+31-20-485-27-36
Source: Elsevier
.
AMSTERDAM, November 2, 2011/PRNewswire-FirstCall/ --
Elsevier, the world-leading publisher of scientific, technical and
medical information products and services, announced today that its 2012
eBook Frontlist collections are available for advance purchase on SciVerse
ScienceDirect, Elsevier's online platform for scientific content. This
release marks a significant increase in the breadth and depth of the eBook
collection on SciVerse ScienceDirect. The 2012 collection covers 23 distinct
subject areas, with individual titles scheduled to publish between January 1
and December 31, 2012.
This year sees an increase in the number of Science and Technology (S&T)
titles, with more than 50% growth strategically delivered in each of the
following top selling collections: Biochemistry, Genetics and Molecular
Biology, Biomedical Science and Medicine, Chemistry and Pharmacology,
Toxicology and Pharmaceutical Science. The chemistry collection alone has
doubled in size while the Health Sciences (HS) Clinical Medicine collection
has increased by 14%. These are all high quality titles, selected for
relevance and published under imprints including Academic Press, Pergamon,
North-Holland, W.B. Saunders, Mosby and Churchill Livingstone.
"Our strategic aim for books on SciVerse ScienceDirect is to grow our
collections in the subjects our customers want and need most, while
retaining our rigorous publication and peer review process to ensure high
quality, " said Suzanne BeDell, Managing Director, Elsevier Science and
Technology Books. "By combining Elsevier's trusted content with the benefits
of accessibility to books, journals, and innovative mobile applications on
the Sciverse ScienceDirect platform, today's academic, government and
corporate institutions are empowered to accelerate research."
Some of the new eBook titles for SciVerse ScienceDirect include:
- Atala/Lanza, Handbook of Stem Cells, 2e
- Crichton, Biological Inorganic Chemistry, 2e
- Wallisch, Matlab for Neuroscientists, 2e
- Waterhouse, Rethinking Autism
- Mettler, Essentials of Nuclear Medicine Imaging, 6e
- Spiro, Clinical Respiratory Medicine, 4e
Librarians, researchers, and those interested in the eBooks 2012
Collections, or any previously published eBooks can visit
http://www.info.sciverse.com/sciencedirect/content/books/lbi
Join our Community:
Facebook http://www.facebook.com/elsevierlibrarians
Twitter http://twitter.com/elsevierscience
About SciVerse ScienceDirect
SciVerse ScienceDirect ( http://www.sciverse.com) contains over a
quarter of the world's full text scientific, technical and medical (STM)
peer-reviewed articles - managed by renowned editors, written by respected
authors and read by researchers from around the globe. Elsevier's extensive
full-text collection covers authoritative titles from the core scientific
literature with more than ten million articles available online. Coverage
includes over 2,500 journal titles published by Elsevier with dynamic
linking to journals from approximately 2,000 STM publishers through
CrossRef. Additionally, SciVerse ScienceDirect contains an expanding library
of online major reference works, handbooks, book series and over 10,000
eBooks in all fields of science seamlessly interlinked with primary research
referenced in journal articles.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Media contact
Harald Boersma
Senior Manager, Corporate Relations, Elsevier
h.boersma@elsevier.com
+31-20-485-27-36
Source: Elsevier
.